Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease? [NA]
A completed clinical trial in Parkinson's disease examined whether cognitive impairment affects rehabilitation outcomes. Sponsored by Ospeda…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease [NA]
This entry notes the completion of a clinical trial investigating how sleep-disordered breathing affects neurocognitive performance and qual…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System
A completed clinical trial assessed whether PET imaging with [11C]Donepezil can visualize the parasympathetic nervous system in Parkinson's …
-
CLINICAL_TRIALS research · 2016-03-22Clinical Trial Update: Subthalamic Nucleus Connectivity in Parkinson's Disease With Ultra-high Field Magnetic Resonance Imaging
An update on a study examining subthalamic nucleus connectivity in Parkinson disease using ultra-high field MRI.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease [Phase 4]
A Phase 4 parallel-group trial evaluating the effect of rasagiline on cognition in patients with Parkinson's disease has been completed and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Biofeedback Rehabilitation in Parkinson's Disease [NA]
The document notes the completion of a clinical trial evaluating biofeedback rehabilitation for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: Deep Brain Stimulation in Patients With Parkinson's Disease [NA]
This clinical trial update reports a completed Mayo Clinic study evaluating deep brain stimulation for patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: A Pilot Study of Oxaloacetate in Subjects With Treated PD [Phase 2, Phase 3]
A Phase 2/3 pilot trial evaluating oxaloacetate in treated Parkinson's disease patients has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls
A completed clinical trial comparing gut-derived neuropeptides in cerebrospinal fluid between Parkinson's disease patients and healthy contr…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Effects of Physical Activity on the Brain in Parkinson's Disease (PD) [NA]
This completed clinical trial evaluated the effects of physical activity on brain function in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease [Phase 2]
Phase 2 study evaluating safety, tolerability, pharmacokinetics, and efficacy of ABT-SLV187 in adults with advanced Parkinson's disease; res…
-
FDA approval · 2016-03-15FDA Approved: RASAGILINE — Original Application (Alvogen, Inc.)
FDA approves an original generic application for rasagiline, a monoamine oxidase-B inhibitor indicated for Parkinson's disease, from Alvogen…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of incobotulinumtoxinA (Xeomin) for Parkinson's tremor; results were posted in 201…
-
FDA approval · 2016-03-14FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Alembic Pharmaceuticals Limited. This action approves a sup…
-
CLINICAL_TRIALS research · 2016-03-14Clinical Trial Update: Biomarker Discovery in Parkinson's Disease
A clinical trial update describing biomarker discovery efforts for Parkinson's disease, with no current status disclosed.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) [Phase 1]
Phase 1 pharmacokinetics study of preladenant in participants with chronic renal impairment completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Behavior Addictions Improvement in Parkinson Disease's Patients Treated by Subthalamic Stimulation : Long Term Follow-up
Long-term follow-up indicates that subthalamic stimulation may improve behavior addictions in patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With PD Undergoing Deep Brain Stimulation [NA]
A completed clinical trial evaluating autologous peripheral nerve grafts implanted into the substantia nigra for Parkinson's disease patient…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers [Phase 1]
This Phase 1 study evaluated safety, tolerability, and pharmacokinetics of PBF-509 at 80 mg, 160 mg, and 240 mg after multiple oral doses in…
-
CLINICAL_TRIALS research · 2016-03-08Clinical Trial Update: Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers [Phase 1]
Phase 1 study evaluating the safety and tolerability of PBF-509 in healthy male volunteers; Parkinson's disease is listed as the associated …
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Aquatic Therapy Versus Land-Based Therapy for the Treatment of Balance Dysfunction in Parkinson's Disease [NA]
A completed clinical trial evaluating aquatic therapy versus land-based therapy for balance dysfunction in Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Effects of Vitamin D in Parkinson's Disease (PD) [Phase 2]
Phase 2 trial evaluating the effects of Vitamin D on Parkinson disease and fall risk; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease
Completion update of a clinical trial investigating striatal and extra-striatal mechanisms of falling in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease [Phase 3]
Open-label extension study evaluating safety and clinical utility of IPX066 in Parkinson's disease; completed Phase 3 trial.
-
FDA approval · 2016-02-25FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination by Sandoz Inc.